The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.
With the rise of biologics, precision medicine and AI-driven drug discovery, clinical research has entered a new and complex ...
Suite of AI-enhanced SaaS solutions automates routine processes and provides a holistic view of trial operations and patient behaviors in real time CAMPBELL, Calif.--(BUSINESS WIRE)--Saama, a provider ...
Identifying copyright holders and response times are major challenges in COA licensing, causing delays in clinical trials. Clear documentation of copyright ownership and standardized response times ...
EVANSTON, Ill.--(BUSINESS WIRE)--Global management consulting and technology firm ZS has announced the launch of ZAIDYN Clinical Development. The offering is the latest expansion of the platform ...
CARMEL, Ind., June 23, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide ...
There are many individuals who can be stakeholders in your projects. Identifying the most crucial stakeholders is key to project success. To identify the most important stakeholders, you’ll want to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback